Euronext Paris · DIM

Sartorius Stedim Biotech SA price

Price history, key statistics, and comparable assets for Sartorius Stedim Biotech SA.

177,90 €

+2.07% (3,60 €)

EUR cached quoteYahoo Finance

Historical prices

Price history

Intraday through long-term closing prices. Choose 1 day, 1 week, 1 month, 6 months, year to date, 1 year, 5 years, or all available history.

Price chart range

1Y daily closing price

177,90 €

Up +6.58% over 1Y

Range low
151,50 €
Range high
222,10 €

Use the left and right arrow keys to inspect prices. On a touch screen, tap the chart to inspect the nearest point.

1Y daily closing-price chart, up 6.58 percent

7 août 20257 août 2026

Point-in-time fields

Key statistics

Previous close
174,30 €
Open
174,00 €
Day range
173,80 € to 180,30 €
52-week range
150,00 € to 224,00 €
Volume
63,61 k
Average volume
80,72 k
Market cap
17,31 Md
P/E ratio (TTM)
59.16

Profile

About Sartorius Stedim Biotech SA

Sartorius Stedim Biotech SA trades on Euronext Paris under DIM and is grouped under Health Technology. Figures marked unavailable are not estimated.

Contextual peers

DIM questions

Sartorius Stedim Biotech SA questions

What is the DIM stock price?

Sartorius Stedim Biotech SA (DIM) had a cached quote of €177.90 as of 2026-08-07T15:35:01.000Z. Market prices move, so this is not an execution quote.

Where does Glide get DIM stock data?

Glide uses Yahoo Finance market data. Quotes and daily history are cached with the original market timestamp, and visiting this page does not contact Yahoo Finance.

Can I access DIM through Glide?

Glide does not list a tokenized DIM product in its current asset registry. This market-data page does not imply that the stock is tradeable on Glide.

Risk and data disclosure

Read before using this data

Glide provides this market data for informational purposes only. It is not investment advice, a recommendation, or an offer to buy or sell any asset. Prices may be delayed or incomplete. Verify market data and consider your objectives, financial situation, and professional advice before acting.

View Yahoo Finance source record